Table 2 Cohort information for locally processed samples used in the ELISA experiments

From: A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer’s disease

 

Sex (F/M, number)

Age at death (yrs, mean ± SD)

Post mortem delay (hr, mean ± SD)

Non-diseased controls (Braak 0−II)

2/2

86.75 ± 8.3

45.38 ± 18.5

Alzheimer’s disease (Braak III−VI)

3/3

78.66 ± 9.6

39.50 ± 16

Back to article page